Dermatomyositis and polymyositis (myositis): vizsgálatok itt: Egyesült Királyság
9 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of AZD0120 in Autoimmune Diseases
- Where
- Edinburgh, London
- Életkor
- 18 év to 75 év
- People
- 27 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07295847 - 3. fázisNot yet taking people in Egyesült KirályságA Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies
- Where
- Birmingham, Bristol, Doncaster, Edinburgh, Harrow, Liverpool, Salford, Wolverhampton
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07789015 · EU 2026-526365-24-00 - 1. fázisTaking peopleA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Where
- Glasgow, London, Southampton
- Életkor
- 18 év to 70 év
- People
- 72 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00 - 3. fázisCsak meghívásosA Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
- Where
- Liverpool, London, Salford
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- argenx
See details and how to joinNCT05979441 · EU 2022-502851-79-00 - 2/3. fázisTaking peopleRESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Where
- London, Manchester, Salford
- Életkor
- 6 év to 75 év
- People
- 74 worldwide
- Run by
- Cabaletta Bio
See details and how to joinNCT06154252 · EU 2025-521145-24-01 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Where
- Edinburgh, London, Wolverhampton
- Életkor
- 18 év to 75 év
- People
- 240 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06455449 - 3. fázisTaking peopleA Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Where
- Doncaster, Glasgow, Salford
- Életkor
- 18 év and over
- People
- 318 worldwide
- Run by
- Pfizer
See details and how to joinNCT05895786 · EU 2022-502739-20-00 - 1. fázisTaking peopleA Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Where
- Cambridge, London, Manchester
- Életkor
- 12 év to 70 év
- People
- 244 worldwide
- Run by
- Fate Therapeutics
See details and how to joinNCT06308978 - No phaseNot yet taking people in Egyesült KirályságIBM Dietary Surveillance Study
- Where
- Manchester
- Életkor
- 40 év and over
- People
- 47
- Run by
- Manchester Metropolitan University
See details and how to joinNCT07535996